Log in to search using one of your social media accounts:

 

Poor Positive Predictive Value of Lyme Disease Serologic Testing in an Area of Low Disease Incidence

Conclusions. In this low-prevalence cohort, fewer than 20% of positive Lyme disease tests are obtained from patients with clinically likely Lyme disease. Positive Lyme disease test results may have little diagnostic value in this setting.
Source: Clinical Infectious Diseases - Category: Infectious Diseases Authors: Tags: ARTICLES AND COMMENTARIES Source Type: research

Related Links:

THE GRIEVING parents of a six-year-old boy who died from Meningitis B are calling for all children to be vaccinated against the deadly strain of the disease.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
This study aimed to perform a systematic review and meta-analysis on the association between vitamin D levels and AA.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: Tags: Research letter Source Type: research
The British Association of Dermatologists provides evidence-based recommendations on the use of biologic therapies for the treatment of psoriasis and psoriatic arthritis in adults and children.The British Journal of Dermatology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
Psoriatic arthritis is the second approved indication for Taltz in the United States.
Source: ConsultantLive - Category: Internal Medicine Authors: Tags: Psoriatic Arthritis Source Type: news
Conclusion: We applied a microsimulation approach to estimate the costs of salmonellosis and its sequelae in Queensland during 2016–2036 under baseline conditions and according to climate change projections. This novel application of microsimulation models demonstrates the models’ potential utility to researchers for examining complex interactions between weather and disease to estimate future costs. https://doi.org/10.1289/EHP1370 Received: 14 November 2016 Revised: 8 November 2017 Accepted: 8 November 2017 Published: 11 December 2017 Address correspondence to D. Stephen, Institute of Health and Biomedica...
Source: EHP Research - Category: Environmental Health Authors: Tags: Research Source Type: research
PDF Version (4.5 MB) About This Article About This Article Supplemental Material Published: 11 December 2017 Note to readers with disabilities: EHP strives to ensure that all journal content is accessible to all readers. However, some figures and Supplemental Material published in EHP articles may not conform to 508 standards due to the complexity of the information being presented. If you need assistance accessing journal content, please contact ehponline@niehs.nih.gov. Our staff will work with you to assess and meet your accessibility needs within 3 working days. Published: 11 December 20...
Source: EHP Research - Category: Environmental Health Authors: Tags: Focus Source Type: research
Psoriatic arthritis is the second approved indication for Taltz in the United States.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Tags: Psoriatic Arthritis Source Type: news
SetPoint Medical said today it won FDA investigational device exemption clearance to launch a trial of its proprietary bioelectronic device designed to treat patients with drug refractory rheumatoid arthritis. The device is designed to be surgically placed on the vagus nerve to activate the body’s natural inflammatory reflex, the Valencia, Calif.-based company said. “We are ready to build on the published positive data from our earlier first-in-human proof-of-concept study of bioelectronic therapy in RA, which significantly improved measures of RA disease activity in this difficult-to-treat patient po...
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Food & Drug Administration (FDA) Pain Management SetPoint Medical Source Type: news
Children are also three times as likely to develop rheumatoid arthritis in later life if their mother had the agonising condition, claim researchers at Odense University Hospital in Denmark
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Condition:   Rheumatoid Arthritis Interventions:   Drug: AZD9567;   Drug: Prednisolone Sponsor:   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arthritis | Endemics | Infectious Diseases | Laboratory Medicine | Lyme Disease | Men | Meningitis | Neurology | Rheumatology | Study